The knowledge of risk factors and prevention of breast cancer in Polish women

Purpose: Currently, breast cancer is one of the most common malignancies among women and it constitutes a significant medical, economic, and social problem. Materials and Methods: The study was conducted in a group of 600 healthy women (aged 18 to 88 years) between September 2011 and February 2015 living in the region of Wielkopolska (Poland) in a private gynecological practice. A survey questionnaire designed specifically for purposes of the study was a tool used to conduct the study. Results: With regards to risk factors for breast cancer: 93% - familial history of breast cancer, 46% - use of hormone treatment, and 40.16% - taking contraceptive pills. Conclusions: A significant component of breast cancer prevention should be providing information regarding prevention tests and increasing accessibility to medical services.

isk factors; Prevention; Breast cancer; Predisposing factors; Familial history; Hormone treatment; Contraceptive pills.

[1] Leźnicka M., Mierzwa T., Jachimowicz–Wołoszynek D., Żyrkowski J.: “The individual invitation system vs. women’s attendance rate at preventive tests performed as a part of oncological prevention programs”. Probl. Hig. Epidemiol., 2009, 90, 627.

[2] Tkaczuk-Włach J., Sobstyl M., Jakiel G.: “Rak piersi – znaczenie profilaktyki pierwotnej i wtórnej”. Menopause Rev., 2012, 4, 343. [Article in Polish]

[3] El Saghir N.S., Anderson B.O.: “Breast cancer early detection and resources: Where in the world do we start?” Breast, 2012, 21, 423.

[4] Połać I., Wilamowska A., Stetkiewicz T., Pertyński T.: “Dense breast – a breast cancer risk factor”. Menopause Rev., 2008, 7, 273. [Article in Polish]

[5] Malicka I., Pawłowska K.: “Physical activity in primary and secondary prevention of breast cancer”. Rehabil Med., 2008, 12, 24. [Article in Polish]

[6] Stasiołek D., Kwaśniewska M., Drygas W.: “Breast cancer: selected risk factors, primary prevention”. Prz Lek., 2002, 59, 26. [Article in Polish]

[7] Horner M.J., Ries L.A.G., Krapcho M., Neyman N., Aminou R., Howlader N., et al.: “SEER cancer Statistics Review, 1975-2006, National Cancer Institute”. Bethesda, MD: National Cancer Institute; 2009 Available at: http://seer.cancer.gov/archive/csr/1975_2006/index.html

[8] Wypych A., Zejda J.E.: “Modes of detection of breast cancer and their diagnostic relevance in urban area of Katowice, Poland”. Probl. Hig. Epidemiol., 2006, 87, 108. [Article in Polish]

[9] Pacian A., Ferenc W., Jędrasik M.: “Young women’s awareness of breast cancer prevention”. Palliative Medicine, 2014, 6, 151. [Article in Polish]

[10] Krzywonos A., Ochałek K., Krzywonos-Zawadzka A., Pitala A.: “Assessment of knowledge of cancer and lymphoedema among breast cancer survivors”. Menopause Rev., 2014, 13, 273.

[11] Narod S.A.: “Hormonal prevention of hereditary breast cancer”. Ann. N. Y. Acad. Sci., 2001, 952, 36.

[12] Marchbanks P.A., Curtis K.M., Mandel M.G., Wilson H.G., Jeng G., Folger S.G., et al.: “Oral contraceptive formulation and risk of breast cancer”. Contraception, 2012, 85, 342.

[13] Grabrick D.M., Hartmann L.C., Cerhan J.R., Vierkant R.A., Therneau T.M., Vachon C.M., et al.: “Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer”. JAMA, 2000, 284, 1791.

[14] Muszyńska A., Mastalerz-Migas A., Brona A.: “Stan wiedzy polskich kobiet na temat profilaktyki raka piersi”. Fam. Med. Prim. Care, Rev., 2006, 8, 708. [Article in Polish]

[15] Humphrey L.L., Helfand M., Chan B.K., Woolf S.H.: “Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force”. Ann. Intern. Med., 2002, 137, 347.

[16] US Preventive Services Task Force: “Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement”. Ann. Intern. Med., 2009, 151, 716.

[17] Didkowska J.: “Wskaźniki zdrowotne chorób nowotworowych w Polsce na tle Europy. Onkologia w praktyce klinicznej”. Wydanie specjalne, 2010, 24.

[18] Tavafian S.S., Hasani L., Aghamolaei T., Zare S., Gregory D.: “Prediction of breast self-examination in a sample of Iranian women: an application of the Health Belief Model”. BMC Womens Health, 2009, 9, 37.

[19] Naghibi S.A., Shojaizadeh D., Montazeri A., Yazdani Cherati J.: “Sociocultural factors associated with breast self-examination among Iranian women”. Acta Med. Iran, 2015, 53, 62.

[20] World Health Organization: “Breast cancer: prevention and control”. Geneva: World Health Organization, 2009. Available at: www.who.int/cancer/detection/ breastcancer/en/index.html

[21] Jurczyk M., Werfel A., Pisarska-Krawczyk M.: “Brachytherapy used in tretment of the breast cancer”. Ginek. Prakt., 2009, 17, 3.

[22] Hammer J., Jurczyk M., Pisarska M., Track Ch., Stanek J., Grodecka-Gazdecka S., et al.: “Interstitial high dose rate 192-Iridium boost in breast cancer treatment”. Prz Ginek. Położ., 2004, 4, 107.